These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22934552)

  • 1. A primary reduced TCA flux governs substrate oxidation in T2D skeletal muscle.
    Gaster M
    Curr Diabetes Rev; 2012 Nov; 8(6):458-79. PubMed ID: 22934552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?
    Gaster M
    Biochem Biophys Res Commun; 2009 Oct; 387(4):651-5. PubMed ID: 19615969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.
    Gaster M
    Biochem Biophys Res Commun; 2009 May; 382(4):766-70. PubMed ID: 19324004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
    Ortenblad N; Mogensen M; Petersen I; Højlund K; Levin K; Sahlin K; Beck-Nielsen H; Gaster M
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):206-14. PubMed ID: 15894466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diabetic phenotype is preserved in myotubes established from type 2 diabetic subjects: a critical appraisal.
    Gaster M
    APMIS; 2019 Jan; 127(1):3-26. PubMed ID: 30549138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
    Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
    Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perilipin 3 Differentially Regulates Skeletal Muscle Lipid Oxidation in Active, Sedentary, and Type 2 Diabetic Males.
    Covington JD; Noland RC; Hebert RC; Masinter BS; Smith SR; Rustan AC; Ravussin E; Bajpeyi S
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3683-92. PubMed ID: 26171795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
    Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
    Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen peroxide production is not primarily increased in human myotubes established from type 2 diabetic subjects.
    Minet AD; Gaster M
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1486-90. PubMed ID: 21733990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes.
    Gaster M
    Biochem Biophys Res Commun; 2011 Jan; 404(4):1023-8. PubMed ID: 21187069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired glucose partitioning in primary myotubes from severely obese women with type 2 diabetes.
    Zou K; Turner K; Zheng D; Hinkley JM; Kugler BA; Hornby PJ; Lenhard J; Jones TE; Pories WJ; Dohm GL; Houmard JA
    Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1011-C1019. PubMed ID: 32966127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotubes from lean and severely obese subjects with and without type 2 diabetes respond differently to an in vitro model of exercise.
    Feng YZ; Nikolić N; Bakke SS; Kase ET; Guderud K; Hjelmesæth J; Aas V; Rustan AC; Thoresen GH
    Am J Physiol Cell Physiol; 2015 Apr; 308(7):C548-56. PubMed ID: 25608533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.
    Thingholm TE; Bak S; Beck-Nielsen H; Jensen ON; Gaster M
    Mol Cell Proteomics; 2011 Sep; 10(9):M110.006650. PubMed ID: 21697546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired TCA cycle flux in mitochondria in skeletal muscle from type 2 diabetic subjects: marker or maker of the diabetic phenotype?
    Gaster M; Nehlin JO; Minet AD
    Arch Physiol Biochem; 2012 Jul; 118(3):156-89. PubMed ID: 22385297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes.
    Gaster M; Rustan AC; Aas V; Beck-Nielsen H
    Diabetes; 2004 Mar; 53(3):542-8. PubMed ID: 14988236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary defects in lipid handling and resistance to exercise in myotubes from obese donors with and without type 2 diabetes.
    Løvsletten NG; Rustan AC; Laurens C; Thoresen GH; Moro C; Nikolić N
    Appl Physiol Nutr Metab; 2020 Feb; 45(2):169-179. PubMed ID: 31276628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
    Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
    J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered tricarboxylic acid cycle flux in primary myotubes from severely obese humans.
    Zou K; Hinkley JM; Park S; Zheng D; Jones TE; Pories WJ; Hornby PJ; Lenhard J; Dohm GL; Houmard JA
    Int J Obes (Lond); 2019 Apr; 43(4):895-905. PubMed ID: 29892037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced incorporation of fatty acids into triacylglycerol in myotubes from obese individuals with type 2 diabetes.
    Sparks LM; Bosma M; Brouwers B; van de Weijer T; Bilet L; Schaart G; Moonen-Kornips E; Eichmann TO; Lass A; Hesselink MKC; Schrauwen P
    Diabetes; 2014 May; 63(5):1583-1593. PubMed ID: 24487026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity.
    He J; Watkins S; Kelley DE
    Diabetes; 2001 Apr; 50(4):817-23. PubMed ID: 11289047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.